Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    An updated revision tag indicates a minor platform update from v3.5.4 to v3.5.5; no study data or page content related to the trial is changed.
    Difference
    0.1%
    Check dated 2026-06-07T14:46:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Updated the page revision from v3.5.3 to v3.5.4, indicating a minor update to the site's versioning or content-management state. No study details or user-facing content were changed.
    Difference
    0.1%
    Check dated 2026-05-17T05:36:50.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-25T17:52:43.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:16:31.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added a new entry for Thyroid gland undifferentiated (anaplastic) carcinoma and a Genetic and Rare Diseases Information Center resources reference.
    Difference
    0.2%
    Check dated 2026-03-27T22:20:46.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0 (v3.5.0 added, v3.4.3 removed).
    Difference
    0.1%
    Check dated 2026-03-20T19:42:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.